Utility of viral kinetics in HCV therapy - It is not over until it is over?
Liver Int
.
2019 May;39(5):815-817.
doi: 10.1111/liv.14047.
Authors
Lisa Sandmann
1
,
Michael P Manns
1
,
Benjamin Maasoumy
1
Affiliation
1
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
PMID:
31020775
DOI:
10.1111/liv.14047
No abstract available
Publication types
Editorial
Comment
MeSH terms
Duration of Therapy*
Hepacivirus
Hepatitis C*
Humans
Kinetics
Liver Cirrhosis
Ribavirin
Substances
Ribavirin